TEAS RF New Application

VISTAAR

DDi - Drug Development informatics

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88209151
Filing Date: 11/28/2018

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88209151
MARK INFORMATION
*MARK \\TICRS\EXPORT17\IMAGEOUT 17\882\091\88209151\xml1\ RFA0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT VISTAAR
COLOR MARK YES
COLOR(S) CLAIMED
(If applicable)
The color(s) BLUE, ORANGE and GREY is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the word VISTAAR in blue color and a + sign in orange and grey color appears in a blue color circle above the letter I.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 944 x 250
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK DDi - Drug Development informatics
INTERNAL ADDRESS DDi - Drug Development informatics
*STREET 4 Independence Way, Suite # 110
*CITY Princeton
*STATE
(Required for U.S. applicants)
New Jersey
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
08540
PHONE 888-931-0060
EMAIL ADDRESS XXXX
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
WEBSITE ADDRESS www.ddismart.com
LEGAL ENTITY INFORMATION
TYPE limited liability company
STATE/COUNTRY WHERE LEGALLY ORGANIZED Nevada
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 042 
*IDENTIFICATION Vistaar is a global regulatory and clinical intelligence platform that combines up to date regulatory content compiled by experts with advanced technology of Artificial Intelligence - AI to deliver a unique regulatory intelligence solution that is both fast and cost-effective. It applies Artificial Intelligence to extract information by automatically fetching, classifying and clustering data and documents into applicable categories like Clinical, Marketing, Lifecycle, Manufacturing, Labeling, Safety and other key areas based on the inbuilt proprietary algorithms that align with regulatory and clinical business goals
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 01/18/2018
       FIRST USE IN COMMERCE DATE At least as early as 01/18/2018
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-9693140227-20181128152024476569_._Vistaar_Web_Page.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT17\IMAGEOUT17\882\091\88209151\xml1\RFA0003.JPG
       SPECIMEN DESCRIPTION Web page screenshot of VISTAAR with logo and description
CORRESPONDENCE INFORMATION
NAME DDi - Drug Development informatics
FIRM NAME DDi - Drug Development informatics
INTERNAL ADDRESS DDi - Drug Development informatics
STREET 4 Independence Way, Suite # 110
CITY Princeton
STATE New Jersey
COUNTRY United States
ZIP/POSTAL CODE 08540
PHONE 888-931-0060
*EMAIL ADDRESS legal@ddismart.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 275
*TOTAL FEE PAID 275
SIGNATURE INFORMATION
SIGNATURE /Prasad Gollamudi/
SIGNATORY'S NAME PRASAD GOLLAMUDI
SIGNATORY'S POSITION LEGAL ASSOCIATE
SIGNATORY'S PHONE NUMBER 888-931-0060
DATE SIGNED 11/28/2018



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88209151
Filing Date: 11/28/2018

To the Commissioner for Trademarks:

MARK: VISTAAR (stylized and/or with design, see mark)

The literal element of the mark consists of VISTAAR.
The color(s) BLUE, ORANGE and GREY is/are claimed as a feature of the mark. The mark consists of the word VISTAAR in blue color and a + sign in orange and grey color appears in a blue color circle above the letter I.
The applicant, DDi - Drug Development informatics, a limited liability company legally organized under the laws of Nevada, having an address of
      DDi - Drug Development informatics
      4 Independence Way, Suite # 110
      Princeton, New Jersey 08540
      United States
      888-931-0060(phone)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 042:  Vistaar is a global regulatory and clinical intelligence platform that combines up to date regulatory content compiled by experts with advanced technology of Artificial Intelligence - AI to deliver a unique regulatory intelligence solution that is both fast and cost-effective. It applies Artificial Intelligence to extract information by automatically fetching, classifying and clustering data and documents into applicable categories like Clinical, Marketing, Lifecycle, Manufacturing, Labeling, Safety and other key areas based on the inbuilt proprietary algorithms that align with regulatory and clinical business goals

In International Class 042, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 01/18/2018, and first used in commerce at least as early as 01/18/2018, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Web page screenshot of VISTAAR with logo and description.

Original PDF file:
SPE0-9693140227-20181128152024476569_._Vistaar_Web_Page.pdf
Converted PDF file(s) (1 page)
Specimen File1



For informational purposes only, applicant's website address is: www.ddismart.com

The applicant's current Correspondence Information:
      DDi - Drug Development informatics
      DDi - Drug Development informatics
      DDi - Drug Development informatics
      4 Independence Way, Suite # 110
      Princeton, New Jersey 08540
      888-931-0060(phone)
      legal@ddismart.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Prasad Gollamudi/   Date: 11/28/2018
Signatory's Name: PRASAD GOLLAMUDI
Signatory's Position: LEGAL ASSOCIATE
Payment Sale Number: 88209151
Payment Accounting Date: 11/29/2018

Serial Number: 88209151
Internet Transmission Date: Wed Nov 28 16:21:15 EST 2018
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XXX-2018112816211592
2857-88209151-6101521ee443d9ddd7edee4790
b138274e1670acb77d3a5cfff7974913c9972-CC
-15981-20181128152024476569

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed